Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDartmouth-Hitchcock Medical Center
About this trial
The purpose of this study is to determine whether an indocyanine green (ICG) fluorescence imaging system (cBPI) can be used to provide surgeons with information about bone health or bone blood flow. This will help surgeons better understand the healing potential of bone and relative risk of complication. This is important to help surgeons select the most appropriate treatment for severe traumatic injuries and infections.
Eligibility criteria
Qualifiers
Patients 18 years of age or older.
Open extremity fracture, planning for management with external fixation, internal fixation or joint fusion.
Fracture Related Infection, planning for management with debridement and possible removal of hardware.
Will have all planned fracture care surgeries performed by a participating surgeon or delegate.
Disqualifiers
Inability of patient to provide informed consent
Fracture of the hand.
Iodine allergy.
Burns at the fracture site.
Trial design
Treatments tested in this trial
- Immunofluorescence Imaging
Treatment groups
10 Participants
are divided into 2 treatment groupsSponsors and collaborators
Dartmouth-Hitchcock Medical Center
Lead sponsor
Dartmouth College
Collaborator
Source ClinicalTrials.gov